GHKs strong antioxidant and anti-inflammatory activity and ability to control post-injury oxidative damage has led to strong research interest in its use to help subjects recover from tissue injury [1, 6]
KLOW results timeline: not established Community reports may describe changes over several weeks, but those reports are not controlled KLOW studies
c e , KL1 increases antibiotic efficacy in human primary neutrophils
Yue and colleagues showed that the GLP-1 agonist, liraglutide, reduced the transcriptional factor KLF2 and the rescued ox-LDL induced reduction of mitogen-activated protein kinase (MAPK) kinase extracellular signal regulated kinase 5 (ERK5) phosphorylation, and blockage of ERK5 activity on KLF2 expression [60]
If you are starting tirzepatide or are in the early weeks of treatment, these strategies can significantly reduce the risk and severity of hair shedding
W.VaughnE.ShekharK.PerezJ